Respiratory Virus Hospitalization Surveillance Network (RESP-NET) Content Implementation Guide, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-resp-net-ig/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
<MedicationAdministration xmlns="http://hl7.org/fhir">
<id value="medicationadministration-oseltamivir"/>
<meta>
<versionId value="1"/>
<lastUpdated value="2020-11-29T02:03:28.045+00:00"/>
<profile
value="http://hl7.org/fhir/us/ecr/StructureDefinition/us-ph-medicationadministration"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>MedicationAdministration Narrative</b></p></div>
</text>
<status value="completed"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="261315"/>
<display value="oseltamivir 75 MG Oral Capsule [Tamiflu]"/>
</coding>
</medicationCodeableConcept>
<subject>🔗
<reference value="Patient/patient-respnet-eve-everywoman"/>
<display value="Eve Everywoman"/>
</subject>
<effectivePeriod>
<start value="2023-10-01T04:30:00+01:00"/>
<end value="2023-10-05T14:30:00+01:00"/>
</effectivePeriod>
<performer>
<actor>🔗
<reference value="Practitioner/practitioner-us-core-henry-seven"/>
</actor>
</performer>
<dosage>
<text value="75mg twice a day for 5 days"/>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral use"/>
</coding>
</route>
<dose>
<value value="75"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</dose>
</dosage>
</MedicationAdministration>